Evidence map›Paper›PMID 29263022›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2018

Cathepsin D plays a role in endothelial-pericyte interactions during alteration of the blood-retinal barrier in diabetic retinopathy.

Finny Monickaraj, Paul McGuire, Arup Das

Open access · bronzeAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. COVID-19-associated Lung Microvascular Endotheliopathy: A "From the Bench" Perspective.American journal of respiratory and critical care medicine · 2022
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Pericyte-Endothelial Interactions in the Retinal Microvasculature.International journal of molecular sciences · 2020
    Review
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Finny MonickarajDepartment of Surgery, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.
Paul McGuireDepartment of Cell Biology and Physiology, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.
Arup DasDepartment of Surgery, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.
University of New Mexico · US

Funding

Inflammatory Chemokines: A Novel Target in Early Diabetic RetinopathyR01EY022327 · NEI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI DAS, ARUP · 2013 to 2015
$1.1M
Sphingosine 1-Phosphate: A New Target for Early Diabetic RetinopathyI01BX001801 · VA · ALBUQUERQUE VA MEDICAL CENTER · PI DAS, ARUP · 2013 to 2015
–
BLRD VA I01 BX001801NEI NIH HHS R01 EY022327
6 · The paper itself

Abstract

Inflammation plays an important role in the pathogenesis of diabetic retinopathy. We have previously demonstrated the effect of cathepsin D (CD) on the mechanical disruption of retinal endothelial cell junctions and increased vasopermeability, as well as increased levels of CD in retinas of diabetic mice. Here, we have also examined the effect of CD on endothelial-pericyte interactions, as well as the effect of dipeptidyl peptidase-4 (DPP4) inhibitor on CD in endothelial-pericyte interactions in vitro and in vivo. Cocultured cells that were treated with pro-CD demonstrated a significant decrease in the expression of platelet-derived growth factor receptor-β, a tyrosine kinase receptor that is required for pericyte cell survival; N-cadherin, the key adherens junction protein between endothelium and pericytes; and increases in the vessel destabilizing agent, angiopoietin-2. The effect was reversed in cells that were treated with DPP4 inhibitor along with pro-CD. With pro-CD treatment, there was a significant increase in the phosphorylation of the downstream signaling protein, PKC-α, and Ca

Indexed as

Cell CommunicationAngiopoietin-2AnimalsBlood-Retinal BarrierCadherinsCalcium-Calmodulin-Dependent Protein Kinase Type 2Calcium SignalingCapillary PermeabilityCathepsin DCell SurvivalCyclic AMP-Dependent Protein KinasesDiabetic RetinopathyEndothelial CellsMaleNerve Tissue ProteinsPericytesAngiopoietin-2CadherinsCalcium-Calmodulin-Dependent Protein Kinase Type 2Cathepsin DCtsd protein, ratCyclic AMP-Dependent Protein KinasesN-cadherin, ratNerve Tissue ProteinsReceptor, Platelet-Derived Growth Factor betaCaMKIICI-MPR/IGF2RDPP4 inhibitorendotheliumPKC-α

Identifiers

PMID29263022
PMCPMC7001867
OpenAlexW2776950827

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.